Patent · US Expired

Treatment of shock using adrenomedullin binding protein-1

US6884781B2 · kind B2 · utility

11Cited by
0References
20Claims
0Family size

Inventor

Key dates

Filing dateDec 5, 2003
Grant dateApr 26, 2005
Priority date—
Expiry dateDec 5, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/1709
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating a mammal in shock or at risk for shock are provided. The methods involve administration of an adrenomedullin binding protein-1 to the mammal. Also provided are methods of preventing or treating a physiologic effect of shock in a mammal. These methods also involve administration of an adrenomedullin binding protein-1 to the mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.